- Why Cryoport
- Who We Serve
- About Us
- News & Events
- Investor Relations
- Contact Us
Cryoport is excited to announce we have signed our second strategic agreement to acquire another company in under a week. Upon closing, Cryoport Inc. will acquire MVE Biological Solutions (“MVE”), a leading manufacturer of vacuum insulated products and cryogenic freezer systems for life sciences markets around the world, from Chart Industries, Inc.
MVE is the leading manufacturer and provider of cryogenic life sciences solutions, providing freezers, dewars and related ancillary equipment used in the storage and transport of life sciences commodities, which include cell and gene therapies. With over 226 dedicated employees and three primary facilities, in Georgia, Minnesota and China, MVE serves over 300 customers.
Working closely with our other family of companies (Cryoport Systems, Cryogene and the pending acquisition of CRYOPDP) MVE will offer complementary solutions to supply the rapidly growing life sciences industry with vital cryogenic storage, transport equipment and systems services. MVE’s aluminum and stainless-steel tanks have been engineered for ultimate reliability and maximizing hold times at the ultra-low cryogenic temperatures crucial to the preservation of critical human and animal tissues and vaccines.
This acquisition represents the beginning of a new era for Cryoport. With this business combination, two life science leaders will come together to create a company with the highest quality and reliability. A unified Cryoport and MVE offering will deliver a unique combination of passionate teams with outstanding industry knowledge; industry-leading global client coverage, advanced temperature-controlled engineering capabilities; and unparalleled temperature controlled supply chain innovation.
Please “stay tuned” for more details about MVE Biological Solutions and Cryoport soon coming your way. For immediate questions and inquiries, please fill out the form below.
To read this full story, check out our Press Release: Cryoport Announces Agreement to Acquire MVE Biological Solutions from Chart Industries